These genes include CCND1 and CD19 (both higher expressed in the PAD non ≥nCR-group) as well as CCND2 and CDK6 (higher expressed in the VAD non ≥nCR-group; Figure 5C). This evidence concerns the gene CD19 and peripheral arterial disease.